Breast cancer patients may now benefit from two of AstraZeneca's existing therapies. The EU has recommended lynparza and enhertu to treat high-risk breast cancer.
from FOX News https://ift.tt/WPEqYGu
via IFTTT
* Please Don't Spam Here. All the Comments are Reviewed by Admin.
